C. Laymon

T. Turkington, C. Laymon, 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

Variations of Dynamic Contrast-Enhanced Magnetic ResonanceImaginginEvaluation

Matthew J. Oborski, Paul Kinahan, R. Kikinis, 2014 .

Failure of the molecular core-particle coupling model in 13C+13C inelastic scattering

D. P. Bybell, C. Laymon, T. Chapuran, 1984 .

Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography

C. Laymon, P. Herscovitch, J. Flynn, 2012, Antimicrobial Agents and Chemotherapy.

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen

Sterling C. Johnson, Matthew D. Zammit, C. Laymon, 2020, Alzheimer's & dementia.

Multimodal magnetic resonance imaging predicts regional amyloid- β burden in the brain

C. Laymon, W. Klunk, Minjie Wu, 2019, bioRxiv.

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults

D. Minhas, C. Laymon, W. Klunk, 2020, Alzheimer's & dementia.

Clinical Value of the First Dedicated, Commercially Available Automatic Injector for Ictal Brain SPECT in Presurgical Evaluation of Pediatric Epilepsy: Comparison with Manual Injection

J. Mountz, A. Panigrahy, C. Laymon, 2013, The Journal of Nuclear Medicine.

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application

Sterling C. Johnson, Ciprian M. Crainiceanu, John Muschelli, 2020, IPMU.

Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging

Matthew J. Oborski, D. Minhas, J. Mountz, 2018, Molecular Imaging and Biology.

Joint‐label fusion brain atlases for dementia research in Down syndrome

D. Minhas, A. Fagan, N. Tustison, 2022, Alzheimer's & dementia.

[18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline

D. Minhas, J. Mountz, C. Laymon, 2019, Front. Neurol..

Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study

D. Minhas, C. Laymon, W. Klunk, 2020, Brain Imaging and Behavior.

The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism.

D. Minhas, O. Lopez, C. Laymon, 2018, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Sleep moderates the relationship between amyloid beta and memory recall

Daniel J Buysse, Kristine A. Wilckens, D. Minhas, 2018, Neurobiology of Aging.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II

Matthew J. Oborski, F. O’Sullivan, Paul Kinahan, 2019, Tomography.

[18F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment

Matthew J. Oborski, F. Lieberman, J. Mountz, 2016, Tomography.

Amyloid accumulation in Down syndrome measured with amyloid load

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2020, Alzheimer's & dementia.

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome

Matthew D. Zammit, C. Laymon, W. Klunk, 2020, Alzheimer's & dementia.

Evaluation of a commercial radiochromatography module as an arterial blood activity monitor

J. Mountz, C. Laymon, J. Price, 2008, Physics in medicine and biology.

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load

D. Minhas, O. Lopez, C. Laymon, 2018, NeuroImage: Clinical.

PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans.

Charles Laymon, Carol Kelley, Koichiro Azuma, 2012, American journal of physiology. Endocrinology and metabolism.

MISPEL: A deep learning approach for harmonizing multi-scanner matched neuroimaging data

Seong Jae Hwang, Mahbaneh Eshaghzadeh Torbati, D. Minhas, 2022 .

Detection of Recurrent Brain Tumor. Comparison of MR Registered Camera-Based and Dedicated PET Images.

Cnmt, T. Turkington, R. Coleman, 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

H. D. Rosas, C. Laymon, W. Klunk, 2022, JAMA neurology.

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome

Young T. Hong, C. Laymon, W. Klunk, 2022, Neurobiology of Aging.

Calculation of attenuation factors from combined singles and coincidence emission projections

T. Turkington, C. Laymon, 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255).

Physical activity, memory function, and hippocampal volume in adults with Down syndrome

Jamie C. Peven, C. Laymon, O. Okonkwo, 2022, Frontiers in Integrative Neuroscience.

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

C. Laymon, B. Kurland, L. Rigatti, 2019, Molecular Imaging and Biology.

The 2H(p?,?)3He and 1H(d?,?)3He reactions below 80 keV

L. L. Kiang, D. R. Tilley, C. Laymon, 1997 .

Weight Loss and Alzheimer's Disease in Down Syndrome.

H. D. Rosas, C. Laymon, B. Ances, 2022, Journal of Alzheimer's disease : JAD.

The Interpreter's one volume commentary on the Bible : introduction and commentary for each book of the Bible including the Apocrypha, with general articles

C. Laymon, 1971 .

The Minor prophets and the Apocrypha : a commentary on Hosea, Joel, Amos, Obadiah, Jonah, Micah, Nahum, Habakkuk, Zephaniah, Haggai, Zechariah, Malachi, the Old Testament Apocrypha

C. Laymon, Charles F. Kraft, 1983 .

Direct Comparison of the Tau PET Tracers 18F-Flortaucipir and 18F-MK-6240 in Human Subjects

D. Minhas, J. Mountz, O. Lopez, 2021, The Journal of Nuclear Medicine.

The interpreter's one-volume commentary on the Bible : including all the books of the Old and New Testaments and the Apocrypha, together with forty-three general articles

C. Laymon, 1972 .

Nuclear Imaging of a Pregnant Patient: Should We Perform Nuclear Medicine Procedures During Pregnancy?

J. Mountz, C. Laymon, G. Bural, 2011, Molecular imaging and radionuclide therapy.

First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

Matthew J. Oborski, F. Lieberman, J. Mountz, 2014, Brain and behavior.

Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2014, Translational oncology.

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome

Sterling C. Johnson, Matthew D. Zammit, C. Laymon, 2021, NeuroImage.

Successful tactile based visual sensory substitution use functions independently of visual pathway integrity

Charles Laymon, Kevin C. Chan, Bedda L. Rosario, 2014, Front. Hum. Neurosci..

Tc-99m Red Blood Cell Bleeding Scan in a Pregnant Woman Presenting With Hematemesis: A Brief Review of Indications and Guidelines for Radionuclide Scans During Pregnancy

J. Mountz, C. Laymon, Michael Scheetz, 2011, Clinical nuclear medicine.

White matter microstructure associations to amyloid burden in adults with Down syndrome

Sterling C. Johnson, Matthew D. Zammit, Patrick J. Lao, 2021, NeuroImage: Clinical.

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study

Sterling C. Johnson, Matthew D. Zammit, A. Alexander, 2021, Journal of Neurodevelopmental Disorders.

Brain imaging: assessing therapy responses using quantitative imaging biomarkers

Matthew J. Oborski, J. Mountz, C. Laymon, 2014 .

Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images

Robert J. Gillies, Ghassan Hamarneh, Payam Ahmadvand, 2020, Tomography.

Acute Regression in Down Syndrome

D. Minhas, C. Laymon, S. O'Bryant, 2021, Brain sciences.

Striatal dopamine supports reward expectation and learning: A simultaneous PET/fMRI study

Finnegan J. Calabro, M. Hallquist, B. Luna, 2022, NeuroImage.

Comparison of longitudinal Aβ in nondemented elderly and Down syndrome

Sterling C. Johnson, Charles M. Laymon, Ann D. Cohen, 2019, Neurobiology of Aging.

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome

Sterling C. Johnson, Matthew D. Zammit, M. Sabbagh, 2021, NeuroImage: Clinical.

The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods

Bradley T. Christian, Charles M. Laymon, Ann D. Cohen, 2018, Alzheimer's & dementia.

A fission ionization detector for neutron flux measurements at a spallation source

Tae-Hoon Lee, S. J. Balestrini, Charles M. Laymon, 1993 .

Correction factors for γ-ray relative intensities in the 66Ga radioisotope

C. Laymon, H. Weller, G. Schmid, 1996 .

Short‐T2 imaging for quantifying concentration of sodium (23Na) of bi‐exponential T2 relaxation

F. Lieberman, J. Mountz, A. Panigrahy, 2015, Magnetic resonance in medicine.

High resolution inelastic gamma-ray measurements with a white neutron source from 1 to 200 MeV

C. Laymon, S. Wender, R. Nelson, 1991 .

Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma

C. Laymon, B. Kurland, C. Anderson, 2018, The Journal of Nuclear Medicine.

Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling.

Xia Li, Ron Kikinis, Wei Huang, 2014, Translational oncology.

Positron emission tomography imaging of D2/3 agonist binding in healthy human subjects with the radiotracer [11C]‐N‐propyl‐norapomorphine: Preliminary evaluation and reproducibility studies

Rajesh Narendran, Steve Kendro, Shivangi Vora, 2009, Synapse.

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects

James M. Mountz, Charles M. Laymon, Ann D. Cohen, 2015, NeuroImage: Clinical.

MISPEL: A supervised deep learning harmonization method for multi-scanner neuroimaging data

Mahbaneh Eshaghzadeh Torbati, D. Minhas, C. DeCarli, 2023, bioRxiv.

A multi-scanner neuroimaging data harmonization using RAVEL and ComBat

Seong Jae Hwang, Mahbaneh Eshaghzadeh Torbati, Erin E. O’Connor, 2021, NeuroImage.

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Sterling C. Johnson, John X. Morris, Omar H. Butt, 2023, The Lancet Neurology.

Simplified FPGA-based data acquisition system for PET

C. Laymon, T. Lewellen, R. Miyaoka, 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

Development of a data acquisition system for the MiCES small animal PET scanner

Thomas K. Lewellen, Paul E. Kinahan, Charles M. Laymon, 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

Recent progress in the development of a micro crystal element (MiCE) PET system

Thomas K. Lewellen, Robert S. Miyaoka, Paul E. Kinahan, 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

Design of a Firewire based data acquisition system for use in animal PET scanners

Paul E. Kinahan, Charles M. Laymon, Robert S. Miyaoka, 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

Imaging properties of a half-inch sodium iodide gamma camera

T. Turkington, R. Coleman, C. Laymon, 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.

Characterization of single and multiple scatter from matter and activity distributions outside the FOV in 3-D PET

R.L. Harrison, C. Laymon, R. Harrison, 2001, IEEE Transactions on Nuclear Science.

Maturation of the human striatal dopamine system revealed by PET and quantitative MRI

D. Minhas, B. Luna, C. Laymon, 2020, Nature Communications.

Registration-based method for determining relative PET/MR left–right image orientation

James M. Mountz, C. R. Becker, Charles M. Laymon, 2008, NeuroImage.

Multi‐site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data

Ghassan Hamarneh, Payam Ahmadvand, Sadek Nehmeh, 2017, Medical physics.

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

Lisa A. Weissfeld, Bedda L. Rosario, Charles M. Laymon, 2010, NeuroImage.

Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions

Charles Laymon, James M. Mountz, Matthew J. Oborski, 2014, PloS one.

A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](−)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum

Diana Martinez, Rajesh Narendran, Steve Kendro, 2010, Journal of Pharmacology and Experimental Therapeutics.

Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET

J. Mountz, C. Laymon, C. Mathis, 2009, Journal of Nuclear Medicine.

FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.

T. Turkington, R. Coleman, C. Laymon, 1999, Radiology.

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.

Paul E Kinahan, Thomas E Yankeelov, John M Buatti, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET.

S. Nehmeh, J. Humm, C. Laymon, 2018, Clinical imaging.

Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2013, Clinical nuclear medicine.

Role of tau deposition in early cognitive decline in Down syndrome

Matthew D. Zammit, C. Laymon, B. Ances, 2022, Alzheimer's & dementia.

Human Biodistribution and Dosimetry of the PET Radioligand [11C]Flumazenil (FMZ)

J. Mountz, C. Laymon, C. Mathis, 2012, Molecular Imaging and Biology.

Calculation of attenuation factors from combined singles and coincidence emission projections

Charles M. Laymon, Timothy G. Turkington, T. Turkington, 1999, IEEE Transactions on Medical Imaging.

Characterizing the emergence of amyloid and tau burden in Down syndrome

Sterling C. Johnson, Matthew D. Zammit, D. Minhas, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.

Matthew D. Zammit, Jamie C. Peven, D. Minhas, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network

Ciprian Catana, Darrin Byrd, Rebecca Christopfel, 2018, Journal of medical imaging.

Polarized Photon Scattering from 4He

C. Laymon, L. Kramer, V. Bellini, 1995 .

Comparison of amyloid accumulation between Down syndrome and autosomal‐dominant Alzheimer disease

Nick C Fox, Omar H. Butt, A. Fagan, 2022, Alzheimer's & Dementia.

Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome

C. Laymon, B. Ances, O. Okonkwo, 2021, Neurobiology of Aging.

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C]PiB amyloid imaging

D. Minhas, C. Laymon, W. Klunk, 2021, EJNMMI Physics.

Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.

Jamie C. Peven, D. Minhas, C. Laymon, 2023, Journal of Alzheimer's disease : JAD.

Informatics methods to enable sharing of quantitative imaging research data.

Fernando Boada, Andre Dekker, Charles Laymon, 2012, Magnetic resonance imaging.

Scatter Correction Requirements for Likelihood-Based Attenuation Artifact Correction in PET

J. Bowsher, C. Laymon, J. Carney, 2006, 2006 IEEE Nuclear Science Symposium Conference Record.

A log likelihood based method for recovery of localized defects in PET attenuation-correction images

J. Bowsher, C. Laymon, J.E. Bowsher, 2004, IEEE Symposium Conference Record Nuclear Science 2004..

Anomaly Detection and Artifact Recovery in PET Attenuation-Correction Images Using the Likelihood Function

James E. Bowsher, Charles M. Laymon, J. Bowsher, 2013, IEEE Journal of Selected Topics in Signal Processing.

Recovery of localized defects in PET attenuation-correction images

J. Bowsher, T. Turkington, C. Laymon, 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2012, Magnetic resonance imaging.

Informatics methods to enable sharing of quantitative imaging research data.

Matthew J. Oborski, J. Mountz, F. Fennessy, 2012, Magnetic resonance imaging.

PET/CT artifacts.

C. Laymon, D. Townsend, J. Carney, 2011, Clinical imaging.

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

Bedda L. Rosario, Jeffrey A. James, C. Laymon, 2010, NeuroImage.

Striatal dopamine supports reward expectation and learning: A simultaneous PET/fMRI study

Finnegan J. Calabro, M. Hallquist, B. Luna, 2022, NeuroImage.

Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's disease

A. Yashin, H. Hakonarson, M. Cuccaro, 2024, Alzheimer's & Dementia.

A multi-scanner neuroimaging data harmonization using RAVEL and ComBat

Seong Jae Hwang, Mahbaneh Eshaghzadeh Torbati, D. Minhas, 2021, NeuroImage.

Comparison of MR-based with 511-keV transmission-based attenuation correction in neuro FDG PET/MR

J. Mountz, C. Laymon, C. Mathis, 2014 .

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.

Paul Kinahan, T. Yankeelov, D. Mankoff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.